Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for early resuscitation in hypovolemic shock
ChiCTR2300079180Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ulinastatin in Hypotensive shock (2 cohorts), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Blood product dosage, Vasoactive drug dosage and 4 more. Started Dec 2023; status: recruiting.
02
Drugs
ulinastatin
03
Conditions
Hypotensive shock
Beyond the preview
Go deeper on ChiCTR2300079180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079180.